help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shane, E.
Right arrow Articles by Factor-Litvak, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shane, E.
Right arrow Articles by Factor-Litvak, P.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 1740-1746, Copyright © 1996 by Endocrine Society


ARTICLES

Fracture after cardiac transplantation: a prospective longitudinal study

E Shane, M Rivas, RB Staron, SJ Silverberg, MJ Seibel, J Kuiper, D Mancini, V Addesso, RE Michler and P Factor-Litvak
Department of Medicine, College of Physicians and Surgeons, Columbia University, School of Public Health, New York, New York 10032, USA.

Cardiac transplantation is associated with increased prevalence of vertebral fractures, but the natural history of and risk factors for fracture after this life-saving procedure are unclear. We evaluated 47 patients (34 men and 13 postmenopausal women) before transplantation with spinal radiographs, determination of bone density by dual energy x- ray absorptiometry, and measurement of biochemical indexes of mineral metabolism. During the first year after transplantation, incident fractures were documented radiographically. Associations among demographic characteristics, bone density, biochemistries, and fracture risk were evaluated with logistic regression analysis. Despite supplementation with elemental calcium (1000 mg/day) and vitamin D (400 IU/day), 17 patients (7 women and 10 men) sustained a total of 34 fractures. Most fractures involved the spine, and 85% of the patients who experienced fracture did so within 6 months of transplantation. Fifty-four percent of the women and 29% of the men experienced fracture. Femoral neck bone mineral density was significantly lower in women who experienced fracture than in those who did not (0.604 +/- 0.11 vs. 0.760 +/- 0.12 g/cm2; P < 0.04), but did not differ in men according to fracture outcome. The amount of bone loss at the femoral neck by 6 months after transplantation was significantly greater in men with fracture than in men without fracture (12.0 +/- 6.4% vs. 6.8 +/- 5.3%; P < 0.04), but did not differ in women according to fracture outcome. Pretransplant 1,25-dihydroxyvitamin D levels were significantly lower (25 +/- 9 vs. 39 +/- 17 pg/mL; P < 0.007) and intact PTH levels tended to be higher in men who did not experience fracture (37 +/- 15 vs. 69 +/- 46 pg/mL; P < 0.06). Individual pretransplant bone density measurements demonstrated substantial overlap between patients who did and did not experience fracture, and normal bone density did not necessarily protect against fracture after transplantation. We conclude that fractures are a common and early complication of cardiac transplantation. No pretransplant measurement has yet been identified that reliably predicts fracture after transplantation in the individual patient.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. R. Ebeling
Approach to the Patient with Transplantation-Related Bone Loss
J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1483 - 1490.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
E. A. Jankowska, J. Jakubaszko, A. Cwynar, J. Majda, B. Ponikowska, D. Kustrzycka-Kratochwil, K. Reczuch, L. Borodulin-Nadzieja, W. Banasiak, P. A. Poole-Wilson, et al.
Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants
Eur J Heart Fail, January 1, 2009; 11(1): 28 - 38.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. Shane, V. Addesso, P. B. Namerow, D. J. McMahon, S.-H. Lo, R. B. Staron, M. Zucker, S. Pardi, S. Maybaum, and D. Mancini
Alendronate versus Calcitriol for the Prevention of Bone Loss after Cardiac Transplantation
N. Engl. J. Med., February 19, 2004; 350(8): 767 - 776.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
L. A. Fitzpatrick
Secondary Causes of Osteoporosis
Mayo Clin. Proc., May 1, 2002; 77(5): 453 - 468.
[Abstract] [PDF]


Home page
RadiologyHome page
T. M. Link, A. Lotter, F. Beyer, S. Christiansen, D. Newitt, Y. Lu, C. Schmid, and S. Majumdar
Changes in Calcaneal Trabecular Bone Structure after Heart Transplantation: An MR Imaging Study
Radiology, December 1, 2000; 217(3): 855 - 862.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. S. DONOVAN Jr., A. PAPADOPOULOS, R. B. STARON, V. ADDESSO, L. SCHULMAN, C. MCGREGOR, F. COSMAN, R. L. LINDSAY, and E. SHANE
Bone Mass and Vitamin D Deficiency in Adults with Advanced Cystic Fibrosis Lung Disease
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1892 - 1899.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Shane, M. Rivas, D. J. McMahon, R. B. Staron, S. J. Silverberg, M. J. Seibel, D. Mancini, R. E. Michler, K. Aaronson, V. Addesso, et al.
Bone Loss and Turnover after Cardiac Transplantation
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1497 - 1506.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society